# Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital

> **NCT07250763** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Inova Health Care Services** · enrollment: 145 (estimated)

## Conditions studied

- Pulmonary Embolism
- Deep Vein Thrombosis
- Atrial Fibrillation
- Acute Cardiac Syndrome
- Mechanical Heart Valve Recipients

## Interventions

- **DRUG:** Initial Heparin Dose Modification

## Key facts

- **NCT ID:** NCT07250763
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-20
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-05-31
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07250763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07250763, "Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07250763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*